M
Overview
Medcan provides proactive health and wellness services with physician-led assessments, comprehensive personalized plans, and ongoing in-person and virtual care across multiple locations. They differentiate by a flagship Annual Health Assessment and a full ecosystem of services for individuals, families, and employers. Goal: help clients take control of their health and live well for life.
Work here?Claim your company
Simplify's Take
What believers are saying
- The Federal Council invited MEDCAN into 2026 legalization consultations.
- CannaTrade 2026 drew national and international speakers, expanding MEDCAN’s network.
- MEDCAN’s 2025 report and 2026 membership push signal sustained grassroots demand.
What critics are saying
- Swiss insurers still reimburse cannabis case-by-case, keeping access expensive and bureaucratic.
- 2026 policy shifts favor licensed medicines, squeezing individualized cannabis therapy demand.
- If legalization sidesteps patient reimbursement, MEDCAN loses relevance and members to cheaper alternatives.
What makes Medcan unique
- MEDCAN is Switzerland’s patient-led medical cannabis voice, not an industry lobby group.
- It pairs advocacy with practical education through CannaTrade 2026 and clinical conferences.
- Its 2026 consultation response separates medical cannabis from recreational legalization debates.
Help us improve and share your feedback! Did you find this helpful?